Quality-of-life scales for patients with drug-resistant partial epilepsy;Quelles échelles de qualité de vie pour les patients ayant une épilepsie partielle pharmaco-résistante

Revue Neurologique

Volumn 160, Issue 5 SUPPL., 2004, Pages

  Villeneuve, N ^a,b  

^a CENTRE SAINT PAUL   (France)

^b Service de Neurophysiologie Clinique   (France)

Author keywords

Adults; Children; Epilepsy; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; TIAGABINE; VIGABATRIN;

AGE DISTRIBUTION; CHRONIC DISEASE; CONFERENCE PAPER; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; FOCAL EPILEPSY; HUMAN; METHODOLOGY; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL PSYCHOLOGY; STANDARDIZATION; SURGICAL TECHNIQUE; ADULT; CHILD; COGNITIVE DEFECT; COMORBIDITY; COMPARATIVE STUDY; DRUG RESISTANCE; EPIDEMIOLOGY; HEALTH SURVEY; HOSPITALIZATION; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; STATISTICS; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CHILD; CHRONIC DISEASE; COGNITION DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSION; DRUG RESISTANCE; EPIDEMIOLOGIC RESEARCH DESIGN; EPILEPSIES, PARTIAL; HEALTH STATUS INDICATORS; HUMANS; NEUROSURGICAL PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4544269203     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (89)

1. AMIR M, ROZINER I, KNOLLA, NEUFELD MY. (1999). Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy. Epilepsie, 40: 216-224.
2. AUSTIN JK, HUSTER GA, DUNN DW. (1996). Adolescent with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia, 37: 1228-1238.
3. AUSTIN JK, SMITH MS, RISINGER MW, MCNELIS AM. (1994). Chilhood epilepsy and asthma: comparaison of quality of life. Epilepsia, 35: 608-615.
4. BAKER GA (A), NASHEF L, VAN HOUT BA. (1997) Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia, 38: S1-8.
5. BAKER GA (B), JACOBY A, BUCK D, STALGIS C, MONNET D. (1997). Quality of life of people with epilepsy: a European study. Epilepsia, 36: 353-362.
6. BAKER GA. (1998). Quality of life and epilepsy: the Liverpool expérience. Clinical thérapeutics, 20: A2-A12.
7. BATTAGLIA D, DI ROCCO C, IUVONE L, et al. (1999). Neuro-cognitive development and epilepsy outcome in children with surgically treated hemimegalencephaly. Neuropediatrics, 30: 307-313.
8. BIRBECK QL, HAYS RD, GUI XINPING, VICKREY B. (2002). Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia, 43: 535-538.
9. BREIER JI, FUCHS KL, BROOKSHIRE BL, WHELESS J, THOMAS AB, CONSTANTINOU J, WILLMORE LJ.(1998). Quality of life perception in patients with intractable epilepsy or pseudoseizures. Arch Neurol, 55: 660-665.
10. BRUNI J. (1999). Gabapentin as adjunctive therapy for partial seizures. Epilepsia, 40: S27-28.
11. BUCK D, JACOBY A, BAKER GA, LEY H, STEEN N. (1999). Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res, 8: 675-685.
12. CAMFIELD C, BREAU L, CAMFIELD P. (2001). Impact of pediatrie epilepsy on the family: a new scale for clinical and research use. Epilepsia, 42: 104-112.
13. CARPAY HA, VERMEULEN J, STROINK H, et al. (1997). Disability due to restrictions in childhood epilepsy. Dev Med Child Neurol, 39: 521-6.
14. COLUNGS JA. (A) (1990). Correlates of wellbeing in a New Zealand epilepsy sample. N Z Med J, 103: 301-303.
15. COLLINS JA. (B) (1990). Psychosocial well-being and epilepsy: an empirical study. Epilepsia, 31: 418-426.
16. CRAMER JA, ARRIGO C, VAN HAMMEE G, GAUER LJ, CEREGHINO JJ. (2000). Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group. Epilepsia, 41: 868-874.
17. CRAMER JA, PERRINE K, DEVINSKY O, BRYANT-COMSTOCK L, MEADOR K, HERMANN B. (1998). Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia, 39:81-88.
18. CRAMER JA, ARRIGO C, VAN HAMMEE G, BROMFIELD EB. (2000). Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res, 41: 29-38.
19. CRAMER JA, BLUM D, REED M, FANNING K; EPILEPSY IMPACT PROJECT GROUP. (2003). The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav, 4: 515-521.
20. DEVINSKY O, VICKREY BG, CRAMER J, PERRINE K, HERMANN B, MEADOR K, HAYS RD. (1995). Development of the quality of life in epilepsy inventory. Epilepsia, 36: 1089-1104.
21. DIMOND KR, PANDE AC, LAMOREAUX L, PIERCE MW. (1996). Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry, 20: 407-417. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry Aug, 20: 1081.
22. DIMOND KR, PANDE AC, LAMOREAUX L, PIERCE MW. (1996). Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry, 20: 407-417. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry Aug, 20: 1081.
23. DODRILL CB, BATZEL LW, QUEISSER HR, TEMKIN NR. (1980). An objective method for the assessment of psychological and social problems among epilepsy. Epilepsia, 1: 123-135.
24. DODRILL CB, ARNETT JL, SOMMERVILLE KW, SUSSMAN NM. (1995). Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia, 36: 164-173.
25. DODRILL CB, BAZEL LW. (1997). Issues in quality of life assessment. In: Engel J, Pedley Jr TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven Publishers: 2227-2231.
26. DODRILL CB, ARNETT JL, HAYES AG, GAROFALO EA, GREELEY CA, GREINER MJ, PIERCE MW. (1999). Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Res, 35: 109-121.
27. DODRILL CB, ARNETT JL, SOMMERVILLE KW, SHU V. (1997). Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology, 48: 1025-1031.
28. DODRILL CB, ARNETT JL, SHU V, PIXTON GC, LENZ GT, SOMMERVILLE KW. (1998). Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsie, 39: 33-42.
29. DODRILL CB, ARNETT JL, DEATON R, LENZ GT, SOMMERVILLE KW. (2000). Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. Epilepsy Res, 42: 123-132.
30. DODRILL CB, ARNETT JL, SOMMERVILLE KW, SUSSMAN NM. (1993). Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology, 43: 2501-2507.
31. ESPIE CA, WATKINS J, DUNCAN R, et al. (2001). Development and validation of the Glasgow Epilepsy Outcome Scale for measuring concerns about epilepsy in people with mental retardation. Epilepsia, 42: 1043-1051.
32. GILLHAM R, KANE K, BRYANT-COMSTOCK L, BRODIE MJ. (2000). A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure, 9: 375-379.
33. GILLHAM R, BRYANT-COMSTOCK L, KANE K. (2000). Validation of the side effect and satisfaction (SEALS) inventory. Seizure, 9: 458-463.
34. GILLIAM F, WYLLIE E, KASHDEN J, et al. (1997). Epilepsy surgery outcome: comprehensive assessment in children. Neurology, 48: 1368-1374.
35. GILLIAM F, KUZNIECKY R, MEADOR K, et al. (1999). Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology, 53: 687-694.
36. HERMANN BP, VICKREY B, HAYS RD, et al. (1996). A comparaison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res, 25: 113-118.
37. HERRMANN C. (1997). International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res, 42: 17-41.
38. HOARE P. (1993). The quality of life of children with chronic epilepsy and their families. Seizure, 2: 269-275.
39. JACOBY A. (1992). Epilepsy and the quality of everyday life: findings from a study of people with well-controlled epilepsy. Soc Sci Med, 34: 657-666.
40. JACOBY A, BAKER G, SMITH D, DEWEY M, CHADWICK D. (1993). Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Res, 16: 83-89.
41. JALAVA M, SILLANPAA M, CAMFIELD C, CAMFIELD P. (1997). Social adjustement and competence 35 years after onset of childhood epilepsy: a prospective controlled study. Epilepsia, 7: 1S-8S.
42. KELLETT MW, SMITH DF, BAKER GA, CHADWICK DW. (1997). Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry, 63: 52-58.
43. KEENE DL, HIGGINS MJ, VENTUREYRA EC. (1997). Outcome and life prospects after surgical management of medically intractable epilepsy in patients under 18 years of age. Childs Nerv Syst, 13: 530-535.
44. KUGOH T. (1996) Quality of life in adult patients with epilepsy. Epilepsia, 37: 37-40.
45. LEHNER J, KALCHMAYR R, SERLES W, et al. (1999). Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure, 8: 88-92.
46. LEIDY NK, ELIXHAUSER A, RENTZ AM, BEACH R, PELLOCK J, SCHATER S, WILLIAM MK. (1999). Telephone validation of the quality of life in epilepsy inventory-89 (QOLIE-89). Epilepsia, 40: 97-106.
47. LINDBERGER M, ALENIUS M, FRISEN L, JOHANNESSEN SI, LARSSON S, MALMGREN K, TOMSON T. (2000). Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Epilepsia, 41: 1289-1295.
48. LUNDGREN J, AMARK P, BLENNOW G, STROMBLAD LG, WALLSTEDT L. (1998). Vagus nerve Stimulation in 16 children with refractory epilepsy. Epilepsia, 39: 809-813.
49. MALMGREN K, SULLIVAN M, EKSTEDT G, KULLBERG G, KUMLIEN E. (1997). Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia, 38: 830-838.
50. MCLACHLAN RS, ROSE KJ, DERRY PA, BONNAR C, BLUME WT, GIRVIN JP. (1997). Health-related quality of life and seizure control in temporal lobe epilepsy. Ann Neurol, 41: 482-489.
51. MCLACHLAN RS, SADLER M, PILLAY N, GUBERMAN A, JONES M, WIEBE S, SCHNEIDERMAN J. (2003). Quality of life after vagus nerve stimulation for intractable epilepsy: is seizure control the only contributing factor? Eur Neurol, 50: 16-19.
52. MAGANTI R, RUTECKI P, BELL B, WOODARD A, JONES JC, RAMIREZ L, ISKANDAR B. (2003). Epilepsy surgery outcome among US veterans. Epilepsy Behav, 4: 723-728.
53. MARKAND ON, SALANOVA V, WHELIHAN E, EMSLEY CL. (2000). Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia, 41: 749-759.
54. MAYER T, SCHUTTE W, WOLF P, ELGER CE. (1999). Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Acta Neurol Scand, 99: 1-7.
55. MIHARA T, INOUE Y, WATANABE Y, et al. (1994). Improvement of quality of life following resective surgery for temporal lobe epilepsy: results of patient and familly assessments. Jpn J Psychiatry Neurol, 48: 221-229.
56. MILLS N, BACHMANN M, HARVEY I, MCGOWAN M, HINE I. (1997). Patients' experience of epilepsy and health care. Fam Pract, 14: 117-123.
57. MITCHELL WG, SCHEIER LM, BAKER SA. (1994). Psychosocial, behavioral, and medical outcomes in children with epilepsy: a developmental risk factor model using longitudinal data. Pediatrics, 94: 471-477.
58. MORTIMORE C, TRIMBLE M, EMMERS E. (1998). Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure, 7: 359-364.
59. NORRBY U, CARLSSON J, BECKUNG E, NORDHOLM L. (1999). Self-assessment of well-being in a group of children with epilepsy. Seizure, 8: 228-234.
60. O'DoNOGHUE MF, GOODRIDGE DM, REDHEAD K, SANDER JW, DUNCAN JS. (1999). Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract, 49: 211-214.
61. PATWARDHAN RV, STONG B, BEBIN EM, MATHISEN J, GRABB PA. (2000). Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery, 47: 1353-1357.
62. PROVINCIALI L, BARTOLINI M, MARI F, DEL PESCE M, CERAVOLO MG. (1996). Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy. Acta Neurol Scand, 94: 12-18.
63. RATY L, HAMRIN E, SODERFELDT B. (1999). Quality of life in newly-debuted epilepsy. An empirical study. Acta Neurol Scand, 100: 221-226.
64. RIBEIRO JL, MENDONCAD, MARTINS DA SIVLVA A. (1998). Impact of epilepsy on QOL in a Portuguese population: exploratory study. Acta Neurol Scand, 97: 287-294.
65. RONEN GM, STREINER DL, ROSENBAUM P. (2003). Health-related quality of life in childhood epilepsy: moving beyond seizure control with minimal adverse effects. Health Qual Life Outcomes, 1: 36.
66. SABAZ M, CAIRNS DR, LAWSON JA, NHEU N, BLEASEL AF, BYE AM. (2000). Validation of a new quality of life measure for children with epilepsy. Epilepsia, 41: 765-774.
67. SABAZ M, CAIRNS DR, LAWSON JA, BLEASEL AF, BYE AM. (2001). The health-related quality of life of children with refractory epilepsy: a comparison of those with and without intellectual disability. Epilepsia, M42: 621-628.
68. SABAZ M, LAWSON JA, CAIRNS DR, DUCHOWNY MS, RESNICK TJ, DEAN PM, BYE AM. (2003). Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients. Epilepsy Behav, 4: 680-691.
69. SEIDMAN-RIPLEY JG, BOUND VK, ANDERMANN F, OLIVIER A, GLOOR P, FEINDEL WH. (1993). Psychosocial consequences of postoperative seizure relief. Epilepsia, 34: 248-254.
70. SELAI CE, SMITH K, TRIMBLE MR. (1999). Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure, 8: 8-13.
71. SELAI CE, ELSTNER K, TRIMBLE MR. (2000). Quality of life pre and post epilepsy surgery. Epilepsy Res, 38: 67-74.
72. SIRVEN JI, SPERLING M, NARITOKU D, et al. (2000). Vagus nerve stimulation therapy for epilepsy in older adults. Neurology, 14: 1179-1182.
73. SMITH D, BAKER G, DAVIES G, DEWEY M, CHADWICK DW. (1993). Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia, 34: 312-322.
74. SPENCER SS, BERG AT, VICKREY BG, et al. (2003). Initial outcomes in the Multicenter Study of Epilepsy Surgery. Neurology, 23: 1680-1685.
75. STAVEM K, KLOSTER R, ROSSBERG E, et al. (2000). Acupuncture in intractable epilepsy: lack of effect on health-related quality of life. Seizure, 9: 422-426.
76. STAVEM K, LOGE JH, KAASA S. (2000). Health status of people with epilepsy compared with a general reference population. Epilepsia, 41: 85-90.
77. STAVEM K, LOSSIUS MI, KVIEN TK, GULDVOG B. (2000). The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res, 9: 865-871.
78. STEINER TJ, DELLAPORTAS CI, FINDLEY LJ, et al. (1999). Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia, 40: 601-607.
79. VAN HOUT B, GAGNON D, SOUETRE RIED S, et al. (1997). Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany and the United Kingdom. Epilepsia, 38: 1221-1226.
80. VICKREY BG, HAYS RD, GRABER J, RAUSCH R, ENGEL J JR, BROOK RH. (1992). A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care, 30: 299-319.
81. VICKREY BG (B), HAYS RD, BROOK RH, RAUSCH R. (1992). Reliability and validity of the Katz Adjustment Scales in an epilepsy sample. Qual Life Res, 1: 63-72.
82. VICKREY BG, HAYS RD, RAUSCH R, SUTHERLING WW, ENGEL J JR, BROOK RH. (1994). Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia, 35: 597-607.
83. VICKREY BG, HAYS RD, RAUSCH R, et al. (1995). Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet, 2: 1445-1449.
84. VICKREY BG, BERG AT, SPERLING MR, et al. (2000): Relationship betwenn seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia, 41: 760-764.
85. WAGNER AK, BUNGAY KM, KOSINSKY M, BROMFIELD EB, EHRENBERG BL. (1996). The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy, 16: 1-9.
86. WIEBE S, BELLHOUSE DR, FALLAHAY C, ELIASZIW M. (1999). Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci, 26: 263-270.
87. WIEBE S. BELLHOUSE DR, FALLAHAY, et al. (1999). Burdeb of epilepsy: the Ontario Health Survey. Can J Neurol Sci, 26: 263-270.
88. WIESE S, BLUME WT, GIRVIN JP, ELIASZIW M. (2001). Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med, 2: 311-318.
89. WIEGARTZ P, SEIDENBERG M, WOODARD A GIDAL B, HERMANN B. (1999). Co-morbid psychiatric disorder in chronic epilepsy: recognition and aetiology of depression. Neurology, 53: 3S-8S.